Your browser doesn't support javascript.
loading
Single-cell analysis of the CD8+ T-cell compartment in multiple myeloma reveals disease specific changes are chiefly restricted to a CD69- subset suggesting potent cytotoxic effectors exist within the tumor bed.
Favaloro, James; Bryant, Christian E; Abadir, Edward; Gardiner, Samuel; Yang, Shihong; King, Tracy; Nassif, Najah; Sedger, Lisa M; Boyle, Richard; Joshua, Douglas E; Ho, P Joy.
Afiliação
  • Favaloro J; Institute of Haematology, Multiple Myeloma Research Laboratory, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, NSW. james.favaloro@health.nsw.gov.au.
  • Bryant CE; Institute of Haematology, Multiple Myeloma Research Laboratory, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW. christian.bryant@health.nsw.gov.au.
  • Abadir E; Institute of Haematology, Multiple Myeloma Research Laboratory, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW.
  • Gardiner S; Sydney Local Health District Clinical Research Institute, Royal Prince Alfred Hospital, Camperdown, NSW.
  • Yang S; Institute of Haematology, Multiple Myeloma Research Laboratory, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW.
  • King T; Institute of Haematology, Multiple Myeloma Research Laboratory, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW.
  • Nassif N; School of Life Sciences, University of Technology Sydney, Ultimo, NSW.
  • Sedger LM; Institute for Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital. Westmead NSW, Sydney, Australia; Centre for Virus research, Westmead Institute for Medical research. Westmead NSW, Sydney.
  • Boyle R; Orthopaedics Department, Sydney Local Health District, Royal Prince Alfred Hospital, Camperdown, NSW.
  • Joshua DE; Institute of Haematology, Multiple Myeloma Research Laboratory, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW.
  • Ho PJ; Institute of Haematology, Multiple Myeloma Research Laboratory, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW.
Haematologica ; 109(4): 1220-1232, 2024 Apr 01.
Article em En | MEDLINE | ID: mdl-37794800
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article